Science

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

Nicholas van As/royalmarsden.nhs.uk

Dec 30, 2024, 12:25

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

A recent paper by Nicholas van As, Medical Director of The Royal Marsden NHS Foundation Trust, was mentioned by Ioannis Goumas, Chief of Urology, Blessed Matteo Clinical Institute, San Donato Group, on X:

“I’m reading ‘At 2 years, 16/32 (50%) prostatectomy and three of 46 (6.5%) SBRT participants used one or more urinary pads daily (p < 0.001)’

And what about all the fancy outcomes of robotic Px?”

“Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial”

Authors: Nicholas van As, Binnaz Yasar, Clare Griffin, Stephanie Burnett, Emma Hall et al.

Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer

Binnaz Yasar cancer Clare Griffin Emma Hall Ioannis Goumas Nicholas van As OncoDaily Oncology prostate cancer Radical Prostatectomy radiotherapy Stephanie Burnett

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology

World Cancer Day: 25 Years of Global Action and Unity in the Fight Against Cancer

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment